Evonik Expands Excipients Portfolio, Launches MaxiPure Polysorbate 80 for Injectable Formulations
Engineered to meet the stringent demands of modern drug development, Evonik's MaxiPure Polysorbate 80 addresses key challenges such as protein stability, viral inactivation, and the consistent solubilisation of hydrophobic active pharmaceutical ingredients (APIs).
Evonik | 24/09/2025 | By Dineshwori | 114
Evonik Opens New Medical Device Application Center in Shanghai to Serve Asian Market
The Evonik Shanghai Medical Device Center is designed to help manufacturers tackle complex challenges and accelerate innovation in medical technologies.
Evonik | 14/07/2025 | By Dineshwori | 150
Evonik Inaugurates New Spray Drying Facility for Pharmaceutical Oral Excipients
Evonik has officially launched a new facility for drying aqueous dispersions of EUDRAGIT polymers at its site in Darmstadt.
Evonik | 11/09/2024 | By Aishwarya | 474
Evonik opens German lipid manufacturing plant
The facility supports the production of all types of custom and proprietary lipids
Evonik | 11/03/2023 | By Sudeep Soparkar | 677
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy